盘龙药业: 独立董事提名人声明与承诺（牛晓峰）

Core Viewpoint - The independent director candidate, Niu Xiaofeng, has been nominated for the fifth board of directors of Shaanxi Panlong Pharmaceutical Group Co., Ltd. by the controlling shareholder, Xie Xiaolin, who has made a public declaration regarding the nomination [1]. Group 1: Nomination Process - The nomination was made after a thorough understanding of the candidate's professional background, education, qualifications, work experience, and any significant dishonesty records [1]. - The candidate has agreed in writing to serve as an independent director [1]. Group 2: Compliance with Regulations - The candidate has passed the qualification review by the company's fourth board of directors' nomination committee [2]. - The candidate does not have any disqualifying conditions as per the Company Law of the People's Republic of China [2]. - The candidate meets the qualifications and conditions for independent directors as stipulated by the China Securities Regulatory Commission and the Shenzhen Stock Exchange [2][3]. Group 3: Independence and Experience - The candidate has participated in training and obtained relevant certification recognized by the stock exchange [2]. - The candidate possesses basic knowledge related to the operation of listed companies and has over five years of relevant work experience in law, economics, management, accounting, or finance [5][10]. - The candidate is not currently serving in any position within the company or its subsidiaries [5]. Group 4: Commitment and Accountability - The nominator guarantees that the declaration is true, accurate, and complete, and is willing to bear legal responsibility for any false statements [10]. - The nominator has authorized the company secretary to submit the declaration to the Shenzhen Stock Exchange and make it public [10]. - If the candidate's independence is compromised during their tenure, the nominator will report this to the board and urge the candidate to resign [10].